@article{Phillips_A-2023_150332,
title = {Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis},
author = {Phillips, A. and Jiang, Y. and Walsh, D. and Andrews, N. and Artama, M. and Clothier, H. and Cullen, L. and Deng, L. and Escolano, S. and Gentile, A. and Gidding, G. and Giglio, N. and Junker, T. and Huang, W. and Janjua, N. and Kwong, J. and Li, J. and Nasreen, S. and Naus, M. and Naveed, Z. and Pillsbury, A. and Stowe, J. and Vo, T. and Buttery, J. and Petousis-Harris, H. and Black, S. and Hviid, A.},
month = {oct},
year = {2023},
abstract = {BackgroundThe Global COVID Vaccine Safety (GCoVS) project was established in 2021 under the multinational Global Vaccine Data Network (GVDN) consortium to facilitate the rapid assessment of the safety of newly introduced vaccines. This study analyzed data from GVDN member sites on the background incidence rates of conditions designated as adverse events of special interest (AESI) for COVID-19 vaccine safety monitoring.},
pages = {6227-6238},
volume = {41},
issue = {42},
journal = {Vaccine},
publisher = {Elsevier},
url = {https://doi.org/10.1016/j.vaccine.2023.08.079},
}
